All material subject to strictly enforced copyright laws. © 2022 Euromoney Institutional Investor PLC group

Sanofi’s €3bn underlines deleveraging trend

French pharmaceutical Sanofi-Aventis is the latest borrower to cut back on the size of its credit facilities as strong cashflows allow borrowers across Europe to deleverage.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Take a Free Trial or Login
We use cookies to provide a personalized site experience.
By continuing to use & browse the site you agree to our Privacy Policy.
I agree